Briefly, using TCR-tg mice and ACT experiments in MOPC315 multiple myeloma, B-lymphoma, and B16 tumor models, the authors described a mechanism in which secreted tumor antigen is taken up by tumor-infiltrating macrophages and presented to CD4+ T cells on MHC-II molecules. Here, CD4 is linked to plasma cell myeloma.